KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Cash from Investing Activities (2016 - 2025)

Jazz Pharmaceuticals (JAZZ) has 16 years of Cash from Investing Activities data on record, last reported at -$372.2 million in Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 92.54% year-over-year to -$372.2 million; the TTM value through Dec 2025 reached -$1.5 billion, down 197.11%, while the annual FY2025 figure was -$1.5 billion, 197.11% down from the prior year.
  • Cash from Investing Activities reached -$372.2 million in Q4 2025 per JAZZ's latest filing, down from -$327.8 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $737.1 million in Q1 2021 and bottomed at -$5.9 billion in Q2 2021.
  • Average Cash from Investing Activities over 5 years is -$392.0 million, with a median of -$129.0 million recorded in 2022.
  • Peak YoY movement for Cash from Investing Activities: surged 1326.92% in 2021, then crashed 5538.82% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$10.1 million in 2021, then plummeted by 3114.21% to -$324.4 million in 2022, then skyrocketed by 131.38% to $101.8 million in 2023, then tumbled by 289.87% to -$193.3 million in 2024, then tumbled by 92.54% to -$372.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$372.2 million in Q4 2025, -$327.8 million in Q3 2025, and -$641.0 million in Q2 2025.